Funder
Shiraz University of Medical Sciences
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Immunology,Immunology and Allergy
Reference30 articles.
1. Shankland KR, Armitage JO, Hancock BW (2012) Non-hodgkin lymphoma. Lancet 380(9844):848–857
2. Ansell SM (2017) Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond. Hematol 2014 Am Soc Hematol Educ Prog Book 2017(1):618–21
3. D’Arena G, Vitale C, Coscia M, Festa A, Di Minno NMD, De Feo V et al (2017) Regulatory T Cells and their prognostic relevance in hematologic malignancies. J Immunol Res 2017:1832968
4. Bates GJ, Fox SB, Han C, Leek RD, Garcia JF, Harris AL et al (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24(34):5373–5380
5. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10(9):942
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献